Tenaya Therapeutics, Inc.

As of May 27, 2025, the technical trend is mildly bearish, influenced by bearish daily moving averages and Bollinger Bands, despite some short-term bullish indicators from the MACD and KST.

Tenaya Therapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $27 million and a market cap of $93.37 million. Key financial metrics include a negative P/E ratio, no dividend yield, and a return on equity of -88.58%.

As of Jun 18, Tenaya Therapeutics, Inc. has a market capitalization of 93.37 million, with net sales of 0.00 million and a net profit of -105.76 million over the latest four quarters. The company reported shareholder's funds of 92.85 million and total assets of 123.33 million as of Dec 24.